Home
Subscribe (free)
About NaturalNews
Contact Us
Write for NaturalNews
Media Info
Advertising Info

Drug patents

Thai Government Deals Patent Blow to Big Pharma's Cancer Drug Monopoly

Thursday, August 21, 2008 by: David Gutierrez, staff writer
Tags: drug patents, health news, Natural News


Most Viewed Articles
https://www.naturalnews.com/023924_drug_cancer_government.html
Delicious
diaspora
Print
Email
Share

(NaturalNews) Health Minister Chaiya Sasomsap said that the government of Thailand will override the patents on three cancer drugs, after pressure from health activists and doctors calling on him to resign. Over the course of five years, the decision is expected to save the government of Thailand, and cost the pharmaceutical companies, more than 3 billion baht ($100 million).

It is not the first time that Thailand has issued compulsory licenses to override the patents on expensive drugs. In 2006, former Health Minister Mongkol na Songkhla overrode the patent on the HIV/AIDS medication Efavirenz, manufactured by Merck.

Mongkol said that a poor nation such as Thailand could not afford to pay patented drug prices for the 63 million people on its national health plan - 80 percent of the country's population. Soon after, he issued compulsory licenses for an Abbot Laboratories AIDS drug and a Sanofi-Aventis heart medicine.

Mongkol also announced patent overrides on three cancer drugs: Letrozole, a Novartis drug for breast cancer; Docetaxel, a Sanofi-Aventis drug for breast and lung cancer; and Erlotinib, a Roche drug for lung, ovarian and pancreatic cancer. But when Chaiya took over as health minister in February 2008, the three affected drug companies launched a lobbying effort to reverse Mongkol's decision.

Chaiya, a businessman with no history in medicine, announced that he would review the decision, calling it "politically correct ... but not legally correct." He also fired the Health Ministry's top negotiator responsible for securing lower prices for foreign drug companies. Outraged doctors and health activists immediately launched a campaign to remove Chaiya from office.

On March 10, Chaiya announced that Mongkol's initial decision would be upheld.

"The findings have convinced me to go ahead with the compulsory licenses, since the ministry's policy is to give patients good access to quality drugs at cheap prices," he said.

In February, drug company Novartis averted a compulsory license on its leukemia drug Glivec by agreeing to provide it to hundreds of Thai patients for free.

Receive Our Free Email Newsletter

Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.


comments powered by Disqus


Natural News Wire (Sponsored Content)

Science.News
Science News & Studies
Medicine.News
Medicine News and Information
Food.News
Food News & Studies
Health.News
Health News & Studies
Herbs.News
Herbs News & Information
Pollution.News
Pollution News & Studies
Cancer.News
Cancer News & Studies
Climate.News
Climate News & Studies
Survival.News
Survival News & Information
Gear.News
Gear News & Information
Glitch.News
News covering technology, stocks, hackers, and more